Both copyright and copyright are a class of drugs called Glucagon-like Peptide-1 receptor agonists . These innovative medicines operate by resembling the body's inherent chemical , GLP-One , to assist reduce blood sugar and stimulate weight loss . This similar mechanism of effect explains why the

Patients struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Semaglutide, is rapidly changing the landscape of weight loss. Approved by regulatory bodies for chronic weight management, Semaglutide acts as a g